000			02081 a2200541 4500
005			20250514210840.0
264		0	_c20050118
008			200501s 0 0 eng d
022			_a0006-2960
024	7		_a10.1021/bi049172p _2doi
040			_aNLM _beng _cNLM
100	1		_aDatta, Bansidhar
245	0	0	_aTreatment of cells with the angiogenic inhibitor fumagillin results in increased stability of eukaryotic initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of extracellular signal-regulated kinases. _h[electronic resource]
260			_bBiochemistry _cNov 2004
300			_a14821-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAlanine _xgenetics
650	0	4	_aAmino Acid Substitution _xgenetics
650	0	4	_aAminopeptidases _xbiosynthesis
650	0	4	_aAngiogenesis Inhibitors _xmetabolism
650	0	4	_aAnimals
650	0	4	_aAspartic Acid _xgenetics
650	0	4	_aCell Line
650	0	4	_aCyclohexanes
650	0	4	_aEnzyme Inhibitors _xmetabolism
650	0	4	_aEnzyme Stability _xdrug effects
650	0	4	_aEukaryotic Initiation Factor-2 _xmetabolism
650	0	4	_aFatty Acids, Unsaturated _xmetabolism
650	0	4	_aFemale
650	0	4	_aGlycoproteins _xbiosynthesis
650	0	4	_aInhibitory Concentration 50
650	0	4	_aMethionyl Aminopeptidases
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMitogen-Activated Protein Kinase 1 _xantagonists & inhibitors
650	0	4	_aMitogen-Activated Protein Kinase 3 _xantagonists & inhibitors
650	0	4	_aMyoblasts, Skeletal _xdrug effects
650	0	4	_aPeptide Fragments _xmetabolism
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aProtein Binding _xdrug effects
650	0	4	_aSesquiterpenes
650	0	4	_aTransfection
700	1		_aMajumdar, Avijit
700	1		_aDatta, Rekha
700	1		_aBalusu, Ramesh
773	0		_tBiochemistry _gvol. 43 _gno. 46 _gp. 14821-31
856	4	0	_uhttps://doi.org/10.1021/bi049172p _zAvailable from publisher's website
999			_c15231087 _d15231087